SCHEMBL1900357

SCHEMBL1900357

CCCCC(C(N)=O)N1CCNCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.58
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
GNAI3 P08754 5/20 0.39
GNAO1 P09471 5/20 0.39
GNAI1 P63096 5/20 0.39
MEN1 O00255 1/20 0.38
PABPC1 P11940 1/20 0.38
KMT2A Q03164 1/20 0.38
EP300 Q09472 1/20 0.35
LMNA P02545 1/20 0.35
CA12 O43570 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA13 Q8N1Q1 1/20 0.35
CA14 Q9ULX7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1905214 0.90 SIGMAR1 (0.47) SIGMAR1CA1CA2LMNACA12
SCHEMBL28816385 0.85 SIGMAR1 (0.59) SIGMAR1CA2GNAI3GNAO1GNAI1
SCHEMBL4559648 0.85 SIGMAR1 (0.43) SIGMAR1OPRD1CHRM5CHRM3
SCHEMBL10413132 0.85 SIGMAR1 (0.43) SIGMAR1GNAI3GNAO1GNAI1EP300
SCHEMBL2875257 0.83 SIGMAR1 (0.47) SIGMAR1CA1CA2MEN1KMT2A
SCHEMBL6032886 0.82 SIGMAR1 (0.41) SIGMAR1GNAI3GNAO1GNAI1MEN1
Hydrochloric Acid SCHEMBL9697226 0.81 MAPT (0.49) SIGMAR1CA1CA2MEN1KMT2A
SCHEMBL2764645 0.81 SIGMAR1 (0.38) SIGMAR1CA1CA2CA12CA9
SCHEMBL28706411 0.81 LMNA (0.45) SIGMAR1CA1CA2GNAI3GNAO1
SCHEMBL28716337 0.81 LMNA (0.45) SIGMAR1CA1CA2LMNACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE42376-E1 Substituted 3-cyanoquinolines WYETH HOLDINGS CORPORATION (US) 2011-05-17 US disclosed
EP-1861376-A1 CIS-2,4,5-TRIARYL-IMIDAZOLINES AND THEIR USE AS ANTI-CANCER MEDICAMENTS F. Hoffmann-Roche AG (CH) 2007-12-05 EP disclosed
WO-2006097261-A1 CIS-2,4,5-TRIARYL-IMIDAZOLINES AND THEIR USE AS ANTI-CANCER MEDICAMENTS F.HOFFMANN-LA ROCHE AG (CH) 2006-09-21 WO disclosed